A patient came to Color with a pancreatic cancer diagnosis from their treating provider. After reviewing the case through our tumor board, to assess the diagnosis. Our clinicians identified that the diagnosis was incorrect. It was instead, cholangiocarcinoma, or bile duct cancer, a different disease requiring a completely different treatment plan, prognosis, and clinical trial options.

Because a partnership had been built with the treating provider from day one, Color caught the error before therapy began, avoided unnecessary treatment, and moved the patient quickly into the right care.

Color isn’t like the traditional model. We take action.

• Correct diagnosis made before treatment through direct peer-to-peer review

• Treating oncologist aligned with Color’s recommendation and updated the care plan

• Special case approval secured in five days for care at a nearby cancer center

A woman with dense breast tissue went through the standard prior authorization and appeal process for an MRI, but the clinical documentation did not fully capture the nuances of her risk. She reached out to Color for help understanding her next steps. Our oncologists reviewed her history, completed the necessary risk calculations, and submitted additional clinical details to her health plan as part of the ongoing appeal. With the full context in place, the plan approved the MRI and she advanced quickly into follow-up care.

Color isn’t like the traditional model. We take action.

• Prior authorization denial was reversed within days

• Coverage was approved for the recommended breast MRI

• The patient began appropriate follow-up care within 5 days

A patient hadn't seen a doctor in more than 20 years when she enrolled with Color. During her clinical assessment, our team identified high-risk symptoms that required urgent attention. 

Color immediately escalated her to diagnostic imaging, ordered a full workup including biopsy and specialist referral, and confirmed a breast cancer diagnosis in just 18 days, compared to the six-month national average.

Color isn’t like the traditional model. We take action.

• Diagnosis confirmed in 18 days instead of 6 months

• $140,000 saved through early Stage Il detection versus Stage IV

• Reconnected patient to ongoing care with a local primary care provider